head of the Cancer Nanomedicine Laboratory at Memorial Sloan Kettering Cancer Center's Molecular Pharmacology Program. "Using specially designed peptides, we can build nanomedicines that make ...

head of the Cancer Nanomedicine Laboratory at Memorial Sloan Kettering Cancer Center's Molecular Pharmacology Program. "Using specially designed peptides, we can build nanomedicines that make ...

The American College of Clinical Pharmacology® (ACCP) published a recent Position Paper entitled "Ensuring the Appropriate Use of Glucagon-Like Peptide-1 Receptor Agonists". Obesity is a multifaceted ...

head of the Cancer Nanomedicine Laboratory at Memorial Sloan Kettering Cancer Center’s Molecular Pharmacology Program. “Using specially designed peptides, we can build nanomedicines that make existing ...

Feb. 5, 2025 /PRNewswire/ -- The American College of Clinical Pharmacology ® (ACCP) published a recent Position Paper entitled "Ensuring the Appropriate Use of Glucagon-Like Peptide-1 Receptor ...

Home > Pressemitteilung: Therapeutic Designer Peptide to ...

Neglected Tropical Diseases (NTDs) remain a significant health burden in tropical and subtropical regions, with limited ...

A Jacobs School of Medicine and Biomedical Sciences researcher has received National Institutes of Health funding to gain better understanding of the neural mechanisms underpinning drug-mediated ...

Daniel Heller, Study Co-Principal Author and Head, Cancer Nanomedicine Laboratory, Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center Highlighting the promise of the peptide ...

Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...